Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 344 (RNA5SP344) is a processed pseudogene that originates from the 5S ribosomal RNA gene family. Pseudogenes are segments of DNA that resemble known genes but are typically non-functional due to mutations or lack of regulatory elements necessary for transcription or translation. RNA5SP344 does not encode a functional 5S ribosomal RNA molecule and is not known to participate in ribosome biogenesis or function. While some pseudogenes can be transcribed and may impact gene regulation (e.g., by acting as competitive endogenous RNAs or antisense regulators), there is no evidence that RNA5SP344 is functional or associated with any disease roles, drug interactions, or therapeutic relevance. It should not be considered a valid drug target, receptor, or biomolecule with direct biomedical utility.
Not applicable; as a pseudogene, it is not directly targeted by therapeutic agents and does not possess an enzymatic or receptor role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 344 (RNA5SP344).